Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1
Authors:
Open Access
- 15 April 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116562
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81972515)
- National Natural Science Foundation of China (82272940)
This publication has 39 references indexed in Scilit:
- Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinomaRedox Biology, 2022
- The hallmarks of cancer metabolism: Still emergingCell Metabolism, 2022
- The ecology of cancer differentiation therapyJournal of Theoretical Biology, 2021
- KLF2 regulates dental pulp-derived stem cell differentiation through the induction of mitophagy and altering mitochondrial metabolismRedox Biology, 2020
- DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivoCancer Letters, 2020
- Mitochondrial dysfunction is implicated in retinoic acid‐induced spina bifida aperta in rat fetusesInternational Journal of Developmental Neuroscience, 2018
- Dysregulated Myogenesis in Rhabdomyosarcoma2017
- Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcomaPediatric Blood & Cancer, 2011
- PAX3–FOXO1 fusion gene in rhabdomyosarcomaCancer Letters, 2008
- Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profilingGene Expression Patterns, 2005